Achilles joins Cen­ter for Break­through Med­i­cines site near Philadel­phia; Catal­ent adds new suites at Kansas City fa­cil­i­ty

A cell ther­a­py bio­phar­ma is join­ing the Cen­ter for Break­through Med­i­cines.

Lon­don-based Achilles Ther­a­peu­tics has inked a deal to get sup­plies for its Phase I …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER